Table of Contents Global Biosimilars Market Professional Survey Report 2017 1 Industry Overview of Biosimilars 1.1 Definition and Specifications of Biosimilars 1.1.1 Definition of Biosimilars 1.1.2 Specifications of Biosimilars 1.2 Classification of Biosimilars 1.2.1 Global Biosimilars Production (K Units) and Growth Rate (%) Comparison by Types (2012-2023) 1.2.2 Global Biosimilars Production Market Share (%) by Types in 2017 1.2.3 Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon) 1.2.4 Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin) 1.2.5 Peptides (Glucagon, Calcitonin) 1.3 Applications of Biosimilars 1.3.1 Global Biosimilars Consumption (K Units) Comparison by Applications (2012-2023) 1.3.2 Oncology 1.3.3 Blood Disorders 1.4 Global BiosimilarsMarket by Regions (2012-2023) 1.4.1 Global Biosimilars Market Size and Growth Rate (%) Comparison by Regions (2012-2023) 1.4.2 North AmericaBiosimilars Status and Prospect (2012-2023) 1.4.3 EuropeBiosimilars Status and Prospect (2012-2023) 1.4.4 ChinaBiosimilars Status and Prospect (2012-2023) 1.4.5 JapanBiosimilars Status and Prospect (2012-2023) 1.4.6 Southeast AsiaBiosimilars Status and Prospect (2012-2023) 1.5 Global Biosimilars Market Size (2012-2023) 1.5.1 Global Biosimilars Revenue (Million USD) Status and Outlook (2012-2023) 1.5.2 Global Biosimilars Capacity, Production (K Units) Status and Outlook (2012-2023) 2 Industrial Chain Analysis 2.1 Industry Chain Structure of Biosimilars 2.2 Raw Material Analysis of Biosimilars 2.2.1 Raw Material A Market Analysis 2.2.2 Raw Material B Market Analysis 2.2.3 Raw Material C Market Analysis 2.3 Labor Cost Analysis of Biosimilars 2.4 Other Costs Analysis of Biosimilars 2.5 Manufacturing Cost Structure Analysis of Biosimilars 2.6 Manufacturing Process Analysis of Biosimilars 2.7 Raw Materials Sources of Biosimilars Major Manufacturers in 2017 2.8 Downstream Buyers of Biosimilars 3 Global Biosimilars Manufacturers Profiles/Analysis 3.1 Pfizer 3.1.1 Company Basic Information, Manufacturing Base and Competitors 3.1.2 Biosimilars Product Category, Application and Specification 3.1.2.1 Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon) 3.1.2.2 Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin) 3.1.2.3 Peptides (Glucagon, Calcitonin) 3.1.3 Pfizer 2017 Biosimilars Sales, Ex-factory Price, Revenue, Gross Margin Analysis 3.1.4 Pfizer 2017 Business Region Distribution Analysis 3.1.5 Pfizer Biosimilars Volume in Different Applications and Its Application Share 3.2 Sandoz International GmbH 3.2.1 Company Basic Information, Manufacturing Base and Competitors 3.2.2 Biosimilars Product Category, Application and Specification 3.2.2.1 Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon) 3.2.2.2 Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin) 3.2.2.3 Peptides (Glucagon, Calcitonin) 3.2.3 Sandoz International GmbH 2017 Biosimilars Sales, Ex-factory Price, Revenue, Gross Margin Analysis 3.2.4 Sandoz International GmbH 2017 Business Region Distribution Analysis 3.2.5 Sandoz International GmbH Biosimilars Volume in Different Applications and Its Application Share 3.3 Teva Pharmaceuticals Industries 3.3.1 Company Basic Information, Manufacturing Base and Competitors 3.3.2 Biosimilars Product Category, Application and Specification 3.3.2.1 Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon) 3.3.2.2 Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin) 3.3.2.3 Peptides (Glucagon, Calcitonin) 3.3.3 Teva Pharmaceuticals Industries 2017 Biosimilars Sales, Ex-factory Price, Revenue, Gross Margin Analysis 3.3.4 Teva Pharmaceuticals Industries 2017 Business Region Distribution Analysis 3.3.5 Teva Pharmaceuticals Industries Biosimilars Volume in Different Applications and Its Application Share 3.4 Amgen Inc 3.4.1 Company Basic Information, Manufacturing Base and Competitors 3.4.2 Biosimilars Product Category, Application and Specification 3.4.2.1 Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon) 3.4.2.2 Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin) 3.4.2.3 Peptides (Glucagon, Calcitonin) 3.4.3 Amgen Inc 2017 Biosimilars Sales, Ex-factory Price, Revenue, Gross Margin Analysis 3.4.4 Amgen Inc 2017 Business Region Distribution Analysis 3.4.5 Amgen Inc Biosimilars Volume in Different Applications and Its Application Share 3.5 Biocon 3.5.1 Company Basic Information, Manufacturing Base and Competitors 3.5.2 Biosimilars Product Category, Application and Specification 3.5.2.1 Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon) 3.5.2.2 Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin) 3.5.2.3 Peptides (Glucagon, Calcitonin) 3.5.3 Biocon 2017 Biosimilars Sales, Ex-factory Price, Revenue, Gross Margin Analysis 3.5.4 Biocon 2017 Business Region Distribution Analysis 3.5.5 Biocon Biosimilars Volume in Different Applications and Its Application Share 3.6 Dr. Reddy's Laboratories 3.6.1 Company Basic Information, Manufacturing Base and Competitors 3.6.2 Biosimilars Product Category, Application and Specification 3.6.2.1 Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon) 3.6.2.2 Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin) 3.6.2.3 Peptides (Glucagon, Calcitonin) 3.6.3 Dr. Reddy's Laboratories Biosimilars Sales, Ex-factory Price, Revenue, Gross Margin Analysis 3.6.4 Dr. Reddy's Laboratories 2017 Business Region Distribution Analysis 3.6.5 Dr. Reddy's Laboratories Biosimilars Volume in Different Applications and Its Application Share 3.7 F. Hoffmann-La Roche 3.7.1 Company Basic Information, Manufacturing Base and Competitors 3.7.2 Biosimilars Product Category, Application and Specification 3.7.2.1 Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon) 3.7.2.2 Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin) 3.7.2.3 Peptides (Glucagon, Calcitonin) 3.7.3 F. Hoffmann-La Roche 2017 Biosimilars Sales, Ex-factory Price, Revenue, Gross Margin Analysis 3.7.4 F. Hoffmann-La Roche 2017 Business Region Distribution Analysis 3.7.5 F. Hoffmann-La Roche Biosimilars Volume in Different Applications and Its Application Share 3.8 Celltrion 3.8.1 Company Basic Information, Manufacturing Base and Competitors 3.8.2 Biosimilars Product Category, Application and Specification 3.8.2.1 Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon) 3.8.2.2 Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin) 3.8.2.3 Peptides (Glucagon, Calcitonin) 3.8.3 Celltrion 2017 Biosimilars Sales, Ex-factory Price, Revenue, Gross Margin Analysis 3.8.4 Celltrion 2017 Business Region Distribution Analysis 3.8.5 Celltrion Biosimilars Volume in Different Applications and Its Application Share 3.9 Samsung Bioepis 3.9.1 Company Basic Information, Manufacturing Base and Competitors 3.9.2 Biosimilars Product Category, Application and Specification 3.9.2.1 Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon) 3.9.2.2 Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin) 3.9.2.3 Peptides (Glucagon, Calcitonin) 3.9.3 Samsung Bioepis 2017 Biosimilars Sales, Ex-factory Price, Revenue, Gross Margin Analysis 3.9.4 Samsung Bioepis 2017 Business Region Distribution Analysis 3.9.5 Samsung Bioepis Biosimilars Volume in Different Applications and Its Application Share 3.10.2.1 Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon) 3.10.2.2 Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin) 3.10.2.3 Peptides (Glucagon, Calcitonin) 4 Technical Data and Manufacturing Plants Analysis of Biosimilars 4.1 Capacity and Commercial Production Date of Global Biosimilars Major Manufacturers in 2017 4.2 Manufacturing Plants Distribution of Global Biosimilars Major Manufacturers in 2017 4.4 R&D Status and Technology Source of Global Biosimilars Major Manufacturers in 2017 4.4 Raw Materials Sources Analysis of Global Biosimilars Major Manufacturers in 2017 5 Global Biosimilars Overall Market Overview 5.1 2012-2017 Overall Market Analysis 5.2 Capacity Analysis 5.2.1 2012-2017 Global Biosimilars Capacity and Growth Rate Analysis 5.2.2 2017 Biosimilars Capacity Analysis (Company Segment) 5.3 Sales Analysis 5.3.1 2012-2017 Global Biosimilars Sales and Growth Rate Analysis 5.3.2 2017 Biosimilars Sales Analysis (Company Segment) 5.4 Sales Price Analysis 5.4.1 2012-2017 Global Biosimilars Sales Price 5.4.2 2017 Biosimilars Sales Price Analysis (Company Segment) 6 Biosimilars Regional Market Analysis 6.1 North America Biosimilars Market Analysis 6.1.1 North America Biosimilars Market Overview 6.1.2 North America 2012-2017 Biosimilars Local Supply, Import, Export, Local Consumption Analysis 6.1.3 North America 2012-2017 Biosimilars Sales Price Analysis 6.1.4 North America 2017 Biosimilars Market Share Analysis 6.2 Europe Biosimilars Market Analysis 6.2.1 Europe Biosimilars Market Overview 6.2.2 Europe 2012-2017 Biosimilars Local Supply, Import, Export, Local Consumption Analysis 6.2.3 Europe 2012-2017 Biosimilars Sales Price Analysis 6.2.4 Europe 2017 Biosimilars Market Share Analysis 6.3 China Biosimilars Market Analysis 6.3.1 China Biosimilars Market Overview 6.3.2 China 2012-2017 Biosimilars Local Supply, Import, Export, Local Consumption Analysis 6.3.3 China 2012-2017 Biosimilars Sales Price Analysis 6.3.4 China 2017 Biosimilars Market Share Analysis 6.4 Japan Biosimilars Market Analysis 6.4.1 Japan Biosimilars Market Overview 6.4.2 Japan 2012-2017 Biosimilars Local Supply, Import, Export, Local Consumption Analysis 6.4.3 Japan 2012-2017 Biosimilars Sales Price Analysis 6.4.4 Japan 2017 Biosimilars Market Share Analysis 6.5 Southeast Asia Biosimilars Market Analysis 6.5.1 Southeast Asia Biosimilars Market Overview 6.5.2 Southeast Asia 2012-2017 Biosimilars Local Supply, Import, Export, Local Consumption Analysis 6.5.3 Southeast Asia 2012-2017 Biosimilars Sales Price Analysis 6.5.4 Southeast Asia 2017 Biosimilars Market Share Analysis 6.6 India Biosimilars Market Analysis 6.6.1 India Biosimilars Market Overview 6.6.2 India 2012-2017 Biosimilars Local Supply, Import, Export, Local Consumption Analysis 6.6.3 India 2012-2017 Biosimilars Sales Price Analysis 6.6.4 India 2017 Biosimilars Market Share Analysis 7 Global 2012-2017 Biosimilars Segment Market Analysis (by Type) 7.1 Global 2012-2017 Biosimilars Sales by Type 7.2 Different Types of Biosimilars Product Interview Price Analysis 7.3 Different Types of Biosimilars Product Driving Factors Analysis 7.3.1 Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon) of Biosimilars Growth Driving Factor Analysis 7.3.2 Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin) of Biosimilars Growth Driving Factor Analysis 7.3.3 Peptides (Glucagon, Calcitonin) of Biosimilars Growth Driving Factor Analysis 8 Global 2012-2017 Biosimilars Segment Market Analysis (by Application) 8.1 Global 2012-2017 Biosimilars Consumption by Application 8.2 Different Application of Biosimilars Product Interview Price Analysis 8.3 Different Application of Biosimilars Product Driving Factors Analysis 8.3.1 Oncology of Biosimilars Growth Driving Factor Analysis 8.3.2 Blood Disorders of Biosimilars Growth Driving Factor Analysis 9 Development Trend of Analysis of Biosimilars Market 9.1 Global Biosimilars Market Trend Analysis 9.1.1 Global 2018-2023 Biosimilars Market Size (Volume and Value) Forecast 9.1.2 Global 2018-2023 Biosimilars Sales Price Forecast 9.2 Biosimilars Regional Market Trend 9.2.1 North America 2018-2023 Biosimilars Consumption Forecast 9.2.2 Europe 2018-2023 Biosimilars Consumption Forecast 9.2.3 China 2018-2023 Biosimilars Consumption Forecast 9.2.4 Japan 2018-2023 Biosimilars Consumption Forecast 9.2.5 Southeast Asia 2018-2023 Biosimilars Consumption Forecast 9.2.6 India 2018-2023 Biosimilars Consumption Forecast 9.3 Biosimilars Market Trend (Product Type) 9.4 Biosimilars Market Trend (Application) 10 Marketing Strategy Analysis, Distributors/Traders 10.1 Marketing Channel 10.1.1 Direct Marketing 10.1.2 Indirect Marketing 10.1.3 Marketing Channel Development Trend 10.2 Market Positioning 10.2.1 Pricing Strategy 10.2.2 Brand Strategy 10.2.3 Target Client 10.3 Distributors/Traders List 11 Biosimilars Marketing Type Analysis 11.1 Biosimilars Regional Marketing Type Analysis 11.2 Biosimilars International Trade Type Analysis 11.3 Traders or Distributors with Contact Information of Biosimilars by Region 11.4 Biosimilars Supply Chain Analysis 12 Consumers Analysis of Biosimilars 12.1 Consumer 1 Analysis 12.2 Consumer 2 Analysis 12.3 Consumer 3 Analysis 12.4 Consumer 4 Analysis 13 Conclusion of the Global Biosimilars Market Professional Survey Report 2018 14 Methodology and Data Source 14.1 Methodology/Research Approach 14.1.1 Research Programs/Design 14.1.2 Market Size Estimation 14.1.3 Market Breakdown and Data Triangulation 14.2 Data Source 14.2.1 Secondary Sources 14.2.2 Primary Sources 14.3 Disclaimer 14.4 Author List

List of Tables and Figures Figure Global Market Size (Million USD) Status and Outlook 2012-2023 Table Global Biosimilars Revenue (Million USD) Comparison by Regions (2012-2023) Table Global Biosimilars Production (K Units) and Revenue (Million USD) Market Split by Product Type Table Global Biosimilars Consumption (K Units) by Application (2016-2023) Figure Picture of Biosimilars Table Product Specifications of Biosimilars Table Global Biosimilars Production (K Units) and Growth Rate (%) Comparison by Types (2012-2023) Figure Global Biosimilars Production Market Share (%) by Types in 2017 Figure Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon) Picture Table Major Manufacturers of Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon) Figure Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin) Picture Table Major Manufacturers of Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin) Figure Peptides (Glucagon, Calcitonin) Picture Table Major Manufacturers of Peptides (Glucagon, Calcitonin) Table Global Biosimilars Consumption (K Units) Comparison by Applications (2012-2023) Figure Global Biosimilars Consumption (K Units) Market Share (%) by Applications in 2017 Figure Oncology Picture Figure Blood Disorders Picture Table Global Biosimilars Revenue (Million USD) Comparison by Regions (2012-2023) Figure North America Biosimilars Revenue (Million USD) and Growth Rate (2012-2023) Figure Europe Biosimilars Revenue (Million USD) and Growth Rate (2012-2023) Figure China Biosimilars Revenue (Million USD) and Growth Rate (2012-2023) Figure Southeast Asia Biosimilars Revenue (Million USD) and Growth Rate (2012-2023) Figure India Biosimilars Revenue (Million USD) and Growth Rate (2012-2023) Figure Japan Biosimilars Revenue (Million USD) and Growth Rate (2012-2023) Figure Global Biosimilars Revenue (Million USD) Status and Outlook (2012-2023) Figure Global Biosimilars Capacity, Production (K Units) Status and Outlook (2012-2023) Figure Industry Chain Structure of Biosimilars Table Raw Material Suppliers and Price Analysis Figure Global Raw Material A Price Trend (USD/MT) Figure Global Raw Material B Price Trend (USD/MT) Figure Global Raw Material C Price Trend (USD/MT) Table Manufacturing Cost Structure Analysis of Biosimilars in 2017 Figure Manufacturing Process Analysis of Biosimilars Table Raw Materials Sources of Biosimilars Major Manufacturers in 2017 Table Major Buyers of Biosimilars Table Pfizer Information List Table Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon) Biosimilars Overview Table Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin) Biosimilars Overview Table Peptides (Glucagon, Calcitonin) Biosimilars Overview Table 2017 Pfizer Biosimilars Revenue, Sales, Ex-factory Price Figure 2017 Pfizer Biosimilars Business Region Distribution Table Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon) Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin) Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Peptides (Glucagon, Calcitonin) Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Pfizer Biosimilars Volume in Oncology and Its Application Share Table Pfizer Biosimilars Volume in Blood Disorders and Its Application Share Table Pfizer Biosimilars Volume in and Its Application Share Table Sandoz International GmbH Information List Table Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon) Biosimilars Overview Table Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin) Biosimilars Overview Table Peptides (Glucagon, Calcitonin) Biosimilars Overview Table 2017 Sandoz International GmbH Biosimilars Revenue, Sales, Ex-factory Price Figure 2017 Sandoz International GmbH Biosimilars Business Region Distribution Table Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon) Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin) Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Peptides (Glucagon, Calcitonin) Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Sandoz International GmbH Biosimilars Volume in Oncology and Its Application Share Table Sandoz International GmbH Biosimilars Volume in Blood Disorders and Its Application Share Table Sandoz International GmbH Biosimilars Volume in and Its Application Share Table Teva Pharmaceuticals Industries Information List Table Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon) Biosimilars Overview Table Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin) Biosimilars Overview Table 2017 Teva Pharmaceuticals Industries Biosimilars Revenue, Sales, Ex-factory Price Figure 2017 Teva Pharmaceuticals Industries Biosimilars Business Region Distribution Table Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon) Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin) Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Peptides (Glucagon, Calcitonin) Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Teva Pharmaceuticals Industries Biosimilars Volume in Oncology and Its Application Share Table Teva Pharmaceuticals Industries Biosimilars Volume in Blood Disorders and Its Application Share Table Teva Pharmaceuticals Industries Biosimilars Volume in and Its Application Share Table Amgen Inc Information List Table Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon) Biosimilars Overview Table Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin) Biosimilars Overview Table Peptides (Glucagon, Calcitonin) Biosimilars Overview Table 2017 Amgen Inc Biosimilars Revenue, Sales, Ex-factory Price Figure 2017 Amgen Inc Biosimilars Business Region Distribution Table Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon) Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin) Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Peptides (Glucagon, Calcitonin) Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Amgen Inc Biosimilars Volume in Oncology and Its Application Share Table Amgen Inc Biosimilars Volume in Blood Disorders and Its Application Share Table Amgen Inc Biosimilars Volume in and Its Application Share Table Biocon Information List Table Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon) Biosimilars Overview Table Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin) Biosimilars Overview Table 2017 Biocon Biosimilars Revenue, Sales, Ex-factory Price Figure 2017 Biocon Biosimilars Business Region Distribution Table Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon) Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin) Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Peptides (Glucagon, Calcitonin) Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Biocon Biosimilars Volume in Oncology and Its Application Share Table Biocon Biosimilars Volume in Blood Disorders and Its Application Share Table Biocon Biosimilars Volume in and Its Application Share Table Dr. Reddy's Laboratories Information List Table Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon) Biosimilars Overview Table Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin) Biosimilars Overview Table 2017 Dr. Reddy's Laboratories Biosimilars Revenue, Sales, Ex-factory Price Figure 2017 Dr. Reddy's Laboratories Biosimilars Business Region Distribution Table Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon) Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin) Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Peptides (Glucagon, Calcitonin) Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Dr. Reddy's Laboratories Biosimilars Volume in Oncology and Its Application Share Table Dr. Reddy's Laboratories Biosimilars Volume in Blood Disorders and Its Application Share Table Dr. Reddy's Laboratories Biosimilars Volume in and Its Application Share Table F. Hoffmann-La Roche Information List Table Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon) Biosimilars Overview Table Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin) Biosimilars Overview Table 2017 F. Hoffmann-La Roche Biosimilars Revenue, Sales, Ex-factory Price Figure 2017 F. Hoffmann-La Roche Biosimilars Business Region Distribution Table Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon) Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin) Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Peptides (Glucagon, Calcitonin) Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table F. Hoffmann-La Roche Biosimilars Volume in Blood Disorders and Its Application Share Table F. Hoffmann-La Roche Biosimilars Volume in and Its Application Share Table Celltrion Information List Table Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon) Biosimilars Overview Table Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin) Biosimilars Overview Table 2017 Celltrion Biosimilars Revenue, Sales, Ex-factory Price Figure 2017 Celltrion Biosimilars Business Region Distribution Table Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon) Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin) Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Peptides (Glucagon, Calcitonin) Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Celltrion Biosimilars Volume in Oncology and Its Application Share Table Celltrion Biosimilars Volume in Blood Disorders and Its Application Share Table Celltrion Biosimilars Volume in and Its Application Share Table Samsung Bioepis Information List Table Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon) Biosimilars Overview Table Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin) Biosimilars Overview Table 2017 Samsung Bioepis Biosimilars Revenue, Sales, Ex-factory Price Figure 2017 Samsung Bioepis Biosimilars Business Region Distribution Table Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon) Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin) Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Peptides (Glucagon, Calcitonin) Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Samsung Bioepis Biosimilars Volume in Oncology and Its Application Share Table Samsung Bioepis Biosimilars Volume in Blood Disorders and Its Application Share Table Samsung Bioepis Biosimilars Volume in and Its Application Share Table Information List Table Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon) Biosimilars Overview Table Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin) Biosimilars Overview Table 2017 Biosimilars Revenue, Sales, Ex-factory Price Figure 2017 Biosimilars Business Region Distribution Table Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon) Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin) Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Peptides (Glucagon, Calcitonin) Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Biosimilars Volume in Oncology and Its Application Share Table Biosimilars Volume in Blood Disorders and Its Application Share Table Biosimilars Volume in and Its Application Share Table Capacity (K Units) and Commercial Production Date of Global Biosimilars Major Manufacturers in 2017 Table Manufacturing Plants Distribution of Global Biosimilars Major Manufacturers in 2017 Table R&D Status and Technology Source of Global Biosimilars Major Manufacturers in 2017 Table Raw Materials Sources Analysis of Global Biosimilars Major Manufacturers in 2017 Table Global Capacity (K Units), Sales (K Units), Price (USD/Unit), Cost (USD/Unit), Sales Revenue (M USD) and Gross Margin of Biosimilars 2012-2017 Figure Global 2012-2017 Biosimilars Sales (K Units) and Growth Rate Figure Global 2012-2017 Biosimilars Market Size (Million USD) and Growth Rate Figure 2012-2017 Global Biosimilars Capacity and Growth Rate Table 2017 Global Biosimilars Capacity List (Company Segment) Figure 2012-2017 Global Biosimilars Sales and Growth Rate Table 2017 Global Biosimilars Sales List (Company Segment) Figure 2012-2017 Global Biosimilars Sales Price Table 2017 Global Biosimilars Sales Price List (Company Segment) Figure North America Capacity Overview Figure North America 2017 Biosimilars Capacity Market Share Table North America Supply, Import, Export and Consumption of Biosimilars 2012-2017 (K Units) Figure North America 2012-2017 Biosimilars Sales Price (USD/Unit) Figure North America 2017 Biosimilars Sales Market Share Figure Europe Capacity Overview Figure Europe 2017 Biosimilars Capacity Market Share Table Europe Supply, Import, Export and Consumption of Biosimilars 2012-2017 (K Units) Figure Europe 2012-2017 Biosimilars Sales Price (USD/Unit) Figure North America 2017 Biosimilars Sales Market Share Figure China Capacity Overview Figure China 2017 Biosimilars Capacity Market Share Table China Supply, Import, Export and Consumption of Biosimilars 2012-2017 (K Units) Figure China 2012-2017 Biosimilars Sales Price (USD/Unit) Figure China 2017 Biosimilars Sales Market Share Figure Japan Capacity Overview Figure Japan 2017 Biosimilars Capacity Market Share Table Japan Supply, Import, Export and Consumption of Biosimilars 2012-2017 (K Units) Figure Japan 2012-2017 Biosimilars Sales Price (USD/Unit) Figure Japan 2017 Biosimilars Sales Market Share Figure Southeast Asia Capacity Overview Figure Southeast Asia 2017 Biosimilars Capacity Market Share Table Southeast Asia Supply, Import, Export and Consumption of Biosimilars 2012-2017 (K Units) Figure Southeast Asia 2012-2017 Biosimilars Sales Price (USD/Unit) Figure Southeast Asia 2017 Biosimilars Sales Market Share Figure India Capacity Overview Figure India 2017 Biosimilars Capacity Market Share Table India Supply, Import, Export and Consumption of Biosimilars 2012-2017 (K Units) Figure India 2012-2017 Biosimilars Sales Price (USD/Unit) Figure India 2017 Biosimilars Sales Market Share Table Global 2012-2017 Biosimilars Sales by Type Table Different Types Biosimilars Product Interview Price Table Global 2012-2017 Biosimilars Sales by Application Table Different Application Biosimilars Product Interview Price Figure Global 2018-2023 Biosimilars Sales (K Units) and Growth Rate Forecast Figure Global 2018-2023 Biosimilars Market Size (Million USD) and Growth Rate Forecast Figure Global 2018-2023 Biosimilars Sales Price (USD/Unit) Forecast Figure North America 2018-2023 Biosimilars Consumption Volume and Growth Rate Forecast Figure Europe 2018-2023 Biosimilars Consumption Volume and Growth Rate Forecast Figure China 2018-2023 Biosimilars Consumption Volume and Growth Rate Forecast Figure Japan 2018-2023 Biosimilars Consumption Volume and Growth Rate Forecast Figure Southeast Asia 2018-2023 Biosimilars Consumption Volume and Growth Rate Forecast Figure India 2018-2023 Biosimilars Consumption Volume and Growth Rate Forecast Table Global Sales Volume (K Units) of Biosimilars by Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin)2018-2023 Table Global Consumption Volume (K Units) of Biosimilars by Blood Disorders2018-2023 Table Distributors/Traders List Table Traders or Distributors with Contact Information of Biosimilars by Regions Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Pfizer Sandoz International GmbH Teva Pharmaceuticals Industries Amgen Inc Biocon Dr. Reddy's Laboratories F. Hoffmann-La Roche Celltrion Samsung Bioepis